Roberta Zappasodi

Also affiliated with College Medical Center, Weill Cornell Medicine

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors”.

CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors

Nature Immunology(2020)10.1038/s41590-019-0589-5

N/A

0.966DataRank · unranked

624 citations

Fabien Franco, Yao-Chen Tsui, Xin Xie, Marcel P. Trefny, Roberta Zappasodi +15 more

A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance

Nature Immunology(2022)10.1038/s41590-022-01141-1

N/A

0.957DataRank · unranked

588 citations

Roberta Zappasodi, Alexander C. Huang

Fundamental immune–oncogenicity trade-offs define driver mutation fitness

Nature(2022)10.1038/s41586-022-04696-z

N/A

0.663DataRank · unranked

82 citations

Roberta Zappasodi, Isabell Schulze, Zachary Sethna, Kelvin C. de Andrade, Dean F. Bajorin +25 more

Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0339

N/A

0.587DataRank · unranked

49 citations

Roberta Zappasodi, Hong Wang, Girish S. Naik, Takami Sato, Todd M. Bauer +13 more

In vitro assays for effector T cell functions and activity of immunomodulatory antibodies

Methods in enzymology on CD-ROM/Methods in enzymology(2020)10.1016/bs.mie.2019.08.012

N/A

0.434DataRank · unranked

17 citations

Sadna Budhu, Mohsen Abu-Akeel, Taha Merghoub, Roberta Zappasodi

Supporting the Next Generation of Scientists to Lead Cancer Immunology Research

Cancer Immunology Research(2021)10.1158/2326-6066.cir-21-0519

N/A

0.121DataRank · unranked

1 citations

Ryan D. Chow, Shadmehr Demehri, Jennifer L. Guerriero, Shashi Gujar, Felix J. Hartmann +24 more

First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-4141

N/A

0.108DataRank · unranked

1 citations

Dana B. Cardin, F. Stephen Hodi, Patricia LoRusso, Taha Merghoub, Roberta Zappasodi +8 more

Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions

The Journal of Experimental Medicine(2022)10.1084/jem.20212169

N/A

0DataRank · unranked

49 citations

Andrew Chow, Levi Mangarin, Heng Pan, Jiajia Zhang, Nicholas Ceglia +21 more

Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine

Nature Communications(2020)10.1038/s41467-020-17750-z

N/A

0DataRank · unranked

480 citations

Sadna Budhu, Jeremy H. Tchaicha, Chien‐Huan Weng, Mathieu Gigoux, Ivan Cohen +13 more

Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade

Journal of Clinical Investigation(2022)10.1172/jci148141

N/A

0DataRank · unranked

28 citations

Judith Michels, Riccardo Mezzadra, Divya Venkatesh, Lauren Dong, Ricardo Gomez +22 more

CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours

Nature(2021)10.1038/s41586-021-03326-4

N/A

0DataRank · unranked

395 citations

Inna Serganova, Ivan Cohen, Masatomo Maeda, Masahiro Shindo, Yasin Şenbabaoğlu +19 more

Targeting GITR in cancer immunotherapy - there is no perfect knowledge

Oncotarget(2023)10.18632/oncotarget.28461

N/A

0DataRank · unranked

23 citations

Roberta Zappasodi, Diwakar Davar

APR-246 increases tumor antigenicity independent of p53

Life Science Alliance(2023)10.26508/lsa.202301999

N/A

0DataRank · unranked

5 citations

Divya Venkatesh, Cailian Liu, Sadna Budhu, Hong Zhong, Mariam M. George +11 more

EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function

Cancer Cell(2024)10.1016/j.ccell.2024.11.006

N/A

0DataRank · unranked

61 citations

Xi Chen, Matt Teater, Ioannis Karagiannidis, Henna S. Nam, Winson Cai +20 more

Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment

Nature Communications(2024)10.1038/s41467-024-47012-1

N/A

0DataRank · unranked

29 citations

Christopher R. Chin, Hsia‐Yuan Ying, Cem Meydan, Matthew Teater, Min Xia +19 more

Germinal Center Dark Zone harbors ATR-dependent determinants of T-cell exclusion that are also identified in aggressive lymphoma

Research Square(2024)10.21203/rs.3.rs-4093618/v1

N/A

0DataRank · unranked

1 citations

Valeria Cancila, Gaia Morello, Giorgio Bertolazzi, Allison Chan, Giulia Bastianello +30 more

Aggressive B cell lymphomas retain ATR-dependent determinants of T cell exclusion from the germinal center dark zone

Journal of Clinical Investigation(2025)10.1172/jci187371

N/A

0DataRank · unranked

1 citations

Giorgio Bertolazzi, Allison Chan, Giovanni Medico, Giulia Bastianello, Gaia Morello +44 more

Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination Therapies

Frontiers in Cell and Developmental Biology(2022)10.3389/fcell.2021.805195

N/A

0DataRank · unranked

24 citations

Sanjukta Chakraborty, Samuel Yamshon, Yusuke Isshiki, Ryan Bucktrout, Ari Melnick +3 more

Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors

Immunity(2021)10.1016/j.immuni.2021.05.003

N/A

0DataRank · unranked

764 citations

Omkar Chaudhary, Patricia Rodríguez-Morales, Xiaoli Sun, Dan Chen, Roberta Zappasodi +23 more

Hallmarks of Resistance to Immune-Checkpoint Inhibitors

Cancer Immunology Research(2022)10.1158/2326-6066.cir-20-0586

N/A

0DataRank · unranked

134 citations

Alexandria P. Cogdill, Paul B. Robbins, Michaela Bowden, Elizabeth M. Burton, Lisa H. Butterfield +17 more